A study recently published in the Journal of the American Society of Nephrology (JASN) states that a good portion of patients fighting Diabetes could actually benefit from heart disease medication! In many type 2 diabetes patients, any measurable degree of urinary protein excretion (including excretions within normal range) increases the likelihood of experiencing heart disease.
It is not uncommon for patients living with type 2 diabetes to experience a condition known as albuminuria, which causes a patient to excrete amplified quantities of protein albumin in their urine.
Diabetic patients suffering from albuminuria have a considerably higher risk of encountering heart attacks, strokes, heart failure, and other heart conditions than other diabetic patients.
A team of researchers led by Dr. Guiseppe Remuzzi, Piero Puggenenti, Esteban Porrini, and others explored what measurable levels of excretion posed a possible danger to diabetic patients. According to Remuzzi, “patients with albuminuria account for at least 90% of the diabetic population.” Through a clinical trial originally designed for other purposes, Dr Remuzzi and his team observed the relationship between protein albumin excretion and heart problems in over 1,200 albuminuric patients also living with type 2 diabetes for an average of 9 years.
Remuzzi and co. observed that any measurable degree of protein excretion came with significant heart conditions. However, the subgroup of observed patients who were prescribed antihypertensive medications showed no link between protein excretion levels and heart disease.
Diabetic patients should speak to their medical care professionals to see if they should investigate options and get help with management of heart disease.